LD-2 disclosure · 2nd Quarter - Report
GRACEWAY PHARMACEUTICALS
via HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP)
Income$10Kfee reported
Client
- Description
- Pharmaceutical manufacturing
- Location
- Tennessee · United States of America
Registrant
- Firm
- HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP)
- Description
- Law Firm
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
1 issueMedical/Disease Research/Clinical Labs
Extension of time to transition asthma inhaler from CFC to non-CFC form.
LobbyistsCANDIDA PEROTTI WOLFF
TargetedSENATE